If you have any questions regarding this letter, pleaseĬontact the Companys legal counsel, Li He of Davis Polk & Wardwell LLP, at +852-2533-3306. The Company respectfully requests that in accordance with Rule 457(p) of the Securities Act, all fees paid to the Commission in connection with theįiling of the Registration Statement be credited to the account of the Company for future use. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477. The Registration Statement has not been declared effective by the Commission and the Company confirms that no securities have been sold pursuant to the Registration Statement. Securities proposed to be covered by the Registration Statement. In light of the current capital markets condition, the Company is considering other alternatives and has determined not to proceed at this time with the offering and sale of the Statement was originally filed by the Company on June 14, 2021. (File No. 333-257089) together with all exhibits thereto (the Registration Statement), effective as of the date hereof or at the earliest practicable date hereafter. Company) hereby respectfully requests that the Securities and Exchange Commission (the Commission) consent to the withdrawal of its Registration Statement on Form F-1 HONG KONG, July 8 (Reuters) - Chinese medical data group LinkDoc Technology Ltd LDOC.O has shelved plans for an IPO in the United States due to Beijing's clampdown on overseas listings by. Pursuant to Rule 477 under the Securities Act of 1933, as amended (the Securities Act), LinkDoc Technology Limited (the Mr. Robert Littlepage, Mr. Jeff Kauten and Mr. Larry Spirgel The Company provides medical big data integration, medical images. Request to Withdrawal of Registration Statement on Form F-1 (File LinkDoc Technology Limited operates as a medical data solutions and oncology big data services provider. listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014.LinkDoc Technology Limited (CIK: 0001854384) this year, according to data compiled by Bloomberg. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. A representative for LinkDoc declined to comment. Reuters reported LinkDoc’s IPO halt earlier Thursday. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. plunged after the government ordered the removal of the ride-hailing giant’s app from local app stores within days of its $4.4 billion U.S. were arranging the deal.Ĭhinese technology stocks suffered a rout after China signaled a new era of tighter oversight over cybersecurity. LinkDoc was slated to price the offering on Thursday, which could have raised as much as $211 million. Market volatility has played a part in the postponement and the Beijing-based medical data company could revisit its listing plans when conditions improve, said one of the people, who asked not to be identified as the information is private. initial public offering, people familiar with the matter said, the first known company to pull out of a debut after China’s government cracked down on overseas listings.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |